Single User License
INR 168900
Site License
INR 337800
Corporate User License
INR 506700

Service Tax Additional

select a format
Price

Single User License
USD 2500
Site License
USD 5000
Corporate User License
USD 7500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Cholelithiasis Global Clinical Trials Review, H1, 2015

Cholelithiasis Global Clinical Trials Review, H1, 2015


  Request for Sample Report

Executive Summary

Cholelithiasis Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Cholelithiasis Global Clinical Trials Review, H1, 2015" provides data on the Cholelithiasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cholelithiasis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cholelithiasis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Cholelithiasis 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Cholelithiasis to Gastrointestinal Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Cholelithiasis to Gastrointestinal Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Unaccomplished Trials of Cholelithiasis 25

Subjects Recruited Over a Period of Time 26

Clinical Trials by Sponsor Type 27

Prominent Sponsors 28

Top Companies Participating in Cholelithiasis Therapeutics Clinical Trials 29

Prominent Drugs 30

Clinical Trial Profiles 31

Clinical Trial Overview of Top Companies 31

USGI Medical, Inc. 31

Clinical Trial Overview of USGI Medical, Inc. 31

Catalysis, S.L. 32

Clinical Trial Overview of Catalysis, S.L. 32

Alternova A/S 33

Clinical Trial Overview of Alternova A/S 33

Clinical Trial Overview of Top Institutes / Government 34

University of California, San Diego 34

Clinical Trial Overview of University of California, San Diego 34

Islamic Azad University of Tabriz 35

Clinical Trial Overview of Islamic Azad University of Tabriz 35

Mansoura University 36

Clinical Trial Overview of Mansoura University 36

G. Hatzikosta General Hospital 37

Clinical Trial Overview of G. Hatzikosta General Hospital 37

Massachusetts General Hospital 38

Clinical Trial Overview of Massachusetts General Hospital 38

University of California, San Francisco 39

Clinical Trial Overview of University of California, San Francisco 39

Universidad Juarez Durango 40

Clinical Trial Overview of Universidad Juarez Durango 40

Hospital Son Llatzer 41

Clinical Trial Overview of Hospital Son Llatzer 41

Kuopio University Hospital 42

Clinical Trial Overview of Kuopio University Hospital 42

University of Missouri 43

Clinical Trial Overview of University of Missouri 43

Five Key Clinical Profiles 44

Appendix 58

Abbreviations 58

Definitions 58

Research Methodology 59

Secondary Research 59

About GlobalData 60

Contact Us 60

Disclaimer 60

Source 61

List of Figures

Cholelithiasis Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Cholelithiasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Cholelithiasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Cholelithiasis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Cholelithiasis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Cholelithiasis Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Cholelithiasis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13

Proportion of Cholelithiasis to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15

Cholelithiasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Cholelithiasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Cholelithiasis to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18

Cholelithiasis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Cholelithiasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Cholelithiasis Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Cholelithiasis Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Cholelithiasis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Cholelithiasis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Cholelithiasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26

Cholelithiasis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 27

Cholelithiasis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28

Cholelithiasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29

Cholelithiasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30

GlobalData Methodology 59

List of Tables

Cholelithiasis Therapeutics, Global, Clinical Trials by Region, 2015* 7

Cholelithiasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Cholelithiasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Cholelithiasis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Cholelithiasis Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Cholelithiasis Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Cholelithiasis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13

Cholelithiasis Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14

Proportion of Cholelithiasis to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15

Cholelithiasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Cholelithiasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Cholelithiasis to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18

Cholelithiasis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Cholelithiasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Cholelithiasis Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Cholelithiasis Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Cholelithiasis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Cholelithiasis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Cholelithiasis Therapeutics, Global, Withdrawn Clinical Trials, 2015* 25

Cholelithiasis Therapeutics, Global, Terminated Clinical Trials, 2015* 25

Cholelithiasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26

Cholelithiasis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 27

Cholelithiasis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28

Cholelithiasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29

Cholelithiasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30

Cholelithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by USGI Medical, Inc., 2015* 31

Cholelithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Catalysis, S.L., 2015* 32

Cholelithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Alternova A/S, 2015* 33

Cholelithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Diego, 2015* 34

Cholelithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Islamic Azad University of Tabriz, 2015* 35

Cholelithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Mansoura University, 2015* 36

Cholelithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by G. Hatzikosta General Hospital, 2015* 37

Cholelithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2015* 38

Cholelithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2015* 39

Cholelithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Universidad Juarez Durango, 2015* 40

Cholelithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Son Llatzer, 2015* 41

Cholelithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Kuopio University Hospital, 2015* 42

Cholelithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Missouri, 2015* 43

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Cholelithiasis Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Cholelithiasis, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.


Related Products in vertical
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com